Lymphocytic Vasculitis
Lymphocytic vasculitis is a form of vascular inflammation characterized by lymphocytic infiltration of blood vessel walls with evidence of vessel wall damage, which can lead to structural and functional impairment of affected vessels.
Definition and Pathology
Lymphocytic vasculitis is defined by:
- Predominant lymphocytic infiltrate involving and surrounding blood vessel walls 1
- Evidence of vessel wall damage, which may include:
- Fibrin deposition within vessel walls
- Endothelial cell hyperplasia
- Lamination by pericytes 2
Unlike leukocytoclastic vasculitis (which is neutrophil-mediated), lymphocytic vasculitis involves T-cell mediated inflammation of blood vessels. The infiltrating lymphocytes are predominantly T cells, with CD4+ cells being dominant 3.
Classification
Lymphocytic vasculitis can be categorized based on:
Vessel size affected:
- Small vessel lymphocytic vasculitis (most common)
- Medium vessel lymphocytic vasculitis
- Large vessel lymphocytic vasculitis (rare)
Morphological patterns:
- Lymphocytic endovasculitis
- Lymphocytic lichenoid vasculitis
- Granulomatous vasculitis 1
Etiology:
- Primary (idiopathic)
- Secondary to underlying conditions
Clinical Presentations
Lymphocytic vasculitis can manifest as:
Cutaneous manifestations:
Systemic manifestations (when part of systemic vasculitis):
- Neurological involvement (peripheral neuropathy, CNS vasculitis)
- Renal involvement
- Pulmonary involvement 6
Associated Conditions
Lymphocytic vasculitis can be associated with:
- Autoimmune diseases (early undifferentiated connective tissue disease, systemic lupus erythematosus) 4
- Drug reactions (most common identifiable cause) 5
- Livedoid vasculopathy (found in 38.3% of cases) 3
- Chronic urticaria 5
- Infections
- Malignancies
Diagnostic Approach
Histopathology (gold standard):
Laboratory studies:
Imaging studies (for systemic involvement):
- MRI (for CNS involvement)
- Angiography (for larger vessel involvement) 6
Treatment
Treatment depends on the underlying cause and severity:
For primary lymphocytic vasculitis:
- Mild cases: Topical or low-dose systemic corticosteroids
- Moderate-severe cases: Higher-dose systemic corticosteroids plus immunosuppressants
For secondary lymphocytic vasculitis:
- Treatment of underlying cause (e.g., discontinuation of offending drug)
- For autoimmune-associated: Immunosuppressive therapy based on the specific condition
- For HCV-associated cryoglobulinemic vasculitis: Antiviral therapy plus immunosuppression if severe 7
For severe or refractory cases:
Prognosis
The prognosis varies depending on:
- Underlying cause
- Extent of organ involvement
- Prompt diagnosis and treatment
- Response to therapy
Early diagnosis and appropriate treatment are essential to prevent irreversible organ damage and improve outcomes.
Key Distinctions
It's important to distinguish lymphocytic vasculitis from:
- Perivascular dermatitis (lacks vessel wall damage)
- Leukocytoclastic vasculitis (neutrophil-predominant)
- Non-vasculitic lymphocytic infiltrates
Some experts debate whether lymphocytic vasculitis represents a specific clinicopathologic entity or a reactive process secondary to severe lymphocytic inflammation 5. However, the presence of vessel wall damage with lymphocytic infiltration remains the key diagnostic feature.